FDA approves first automated insulin delivery device for type 1 diabetes

The U.S. Food and Drug Administration recently approved Medtronic’s MiniMed 670G hybrid closed looped system, the first FDA-approved device that is intended to automatically monitor glucose (sugar) and provide appropriate basal insulin doses in people 14 years of age and older with type 1 diabetes.

The U.S. Food and Drug Administration recently approved Medtronic’s MiniMed 670G hybrid closed looped system, the first FDA-approved device that is intended to automatically monitor glucose (sugar) and provide appropriate basal insulin doses in people 14 years of age and older with type 1 diabetes.

Link:
FDA approves first automated insulin delivery device for type 1 diabetes